4 November 2020Monitor infant for gastro-intestinal disturbances and oral candida infection, especially if used for prolonged periods or in high doses, although these effects are unlikely to…
Medicine Compliance Aid Stability
FucidinLeo Laboratories Ltd
Leo Laboratories Ltd
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Powder is hygroscopic. store in airtight container. Maximum 7 days in MCA.
7 May 2015
Lactation Safety Information
Oral / Parenteralsee fusidic acid for topical uses
Oral / Parenteral
see fusidic acid for topical uses
Alternative microbiologically appropriate antibiotic
No published evidence of safety
Used in full-term neonates from birth
Present in milk but amount not quantified.
11 August 2020